Safeguard Stock Executives

SFE -  USA Stock  

USD 7.59  0.14  1.81%

Safeguard Scientifics employes about 33 people. The company is managed by 21 executives with total tenure of roughly 130 years, averaging almost 6.0 years of service per executive having 1.57 employees per reported executive. Evaluation of Safeguard Scientifics management performance can provide insight into the firm performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Safeguard Scientifics future performance.
Additionally, take a look at World Market Map.

Search Insiders 

  Stephen Zarrilli  CEO
President CEO, Director
  Robert Rosenthal  Chairman
Executive Chairman of the Board, Principal Executive Officer
  Andrew Lietz  Chairman
Independent Chairman of the Board

Safeguard Scientifics Return on Sales


Safeguard Scientifics Management Team Effectiveness

Safeguard Scientifics has Return on Asset of (4.39) % which means that on every $100 spent on asset, it lost $4.39. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (4.77) %, meaning that it generated no profit with money invested by stockholders. Safeguard Scientifics management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Sales is expected to grow to 2.52, whereas Return on Investment is forecasted to decline to (6.63) . Safeguard Scientifics Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 16.06 Million. The current year Assets Non Current is expected to grow to about 179.1 M, whereas Return on Average Assets are forecasted to decline to (43.72) .
Safeguard Scientifics Weighted Average Shares Diluted is projected to decrease significantly based on the last few years of reporting. The past year's Weighted Average Shares Diluted was at 20.75 Million

Safeguard Scientifics Workforce Comparison

Safeguard Scientifics is rated below average in number of employees category among related companies. The total workforce of Asset Management industry is at this time estimated at about 293,338. Safeguard Scientifics adds roughly 33.0 in number of employees claiming only tiny portion of stocks in Asset Management industry.

Safeguard Scientifics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Safeguard Scientifics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Safeguard Scientifics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Safeguard Scientifics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Safeguard Scientifics Benchmark Summation

The output start index for this execution was zero with a total number of output elements of sixty-one. Safeguard Scientifics Price Series Summation is a cross summation of Safeguard Scientifics price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

Safeguard Scientifics Notable Stakeholders

A Safeguard Scientifics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Safeguard Scientifics often face trade-offs trying to please all of them. Safeguard Scientifics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Safeguard Scientifics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stephen Zarrilli - President CEO, DirectorProfile
Robert Rosenthal - Executive Chairman of the Board, Principal Executive OfficerProfile
Andrew Lietz - Independent Chairman of the BoardProfile
Scott Snyder - Senior Vice President Managing Director, Chief Technology and Innovation OfficerProfile
Mark Herndon - Chief Financial Officer, Senior Vice PresidentProfile
John Shave - Vice President - Business Development and Corporate CommunicationsProfile
Jeffrey McGroarty - CFO, Senior Vice President - FinanceProfile
Brian Sisko - Executive Vice President Managing DirectorProfile
David Kille - CFOProfile
Julie Dobson - Independent DirectorProfile
Ira Lubert - Independent DirectorProfile
Russell Glass - Independent DirectorProfile
George MacKenzie - Independent DirectorProfile
Jack Messman - Independent DirectorProfile
John Roberts - Independent DirectorProfile
Stephen Fisher - Independent DirectorProfile
Maureen Morrison - Independent DirectorProfile
Mara Aspinall - DirectorProfile
Joseph Manko - Independent DirectorProfile
Albert II - Sr. VP and Managing Director of HealthcareProfile
Eric Salzman - Chief Restructuring OfficerProfile

About Safeguard Scientifics Management Performance

The success or failure of an entity such as Safeguard Scientifics often depends on how effective the management is. Safeguard Scientifics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Safeguard management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Safeguard management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Last ReportedProjected for 2021
Return on Investment(6.14) (6.63) 
Return on Average Assets(42.60) (43.72) 
Return on Average Equity(45.70) (46.91) 
Return on Invested Capital(0.24) (0.25) 
Return on Sales 2.34  2.52 
It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts. Safeguard Scientifics operates under Asset Management classification in the United States and is traded on New York Stock Exchange.
The data published in Safeguard Scientifics' official financial statements usually reflect Safeguard Scientifics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Safeguard Scientifics. For example, before you start analyzing numbers published by Safeguard accountants, it's critical to develop an understanding of what Safeguard Scientifics' liquidity, profitability, and earnings quality are in the context of the Financial Services space in which it operates.
Please note, the presentation of Safeguard Scientifics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Safeguard Scientifics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Safeguard Scientifics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Safeguard Scientifics. Please utilize our Beneish M Score to check the likelihood of Safeguard Scientifics' management to manipulate its earnings.

Safeguard Scientifics Workforce Analysis

Traditionally, organizations such as Safeguard Scientifics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Safeguard Scientifics within its industry.

Safeguard Scientifics Manpower Efficiency

Return on Safeguard Scientifics Manpower

Revenue Per Employee1.1 M
Revenue Per Executive1.7 M
Net Loss Per Employee794 K
Net Loss Per Executive189.5 K
Working Capital Per Employee1.9 M
Working Capital Per Executive3 M
Today, most investors in Safeguard Scientifics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Safeguard Scientifics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's per employee growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Safeguard Scientifics per employee as a starting point in their analysis.

Per Employee

Safeguard Scientifics Per Employee Growth Over Time

Net Income Per Employee

Safeguard Scientifics Net Income Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Net Income Per Employee was at (773,677)

Revenue Per Employee

1.07 MillionShare
Safeguard Scientifics Revenue Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Revenue Per Employee was at 1.08 Million
Additionally, take a look at World Market Map. Note that the Safeguard Scientifics information on this page should be used as a complementary analysis to other Safeguard Scientifics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Safeguard Stock analysis

When running Safeguard Scientifics price analysis, check to measure Safeguard Scientifics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safeguard Scientifics is operating at the current time. Most of Safeguard Scientifics' value examination focuses on studying past and present price action to predict the probability of Safeguard Scientifics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Safeguard Scientifics' price. Additionally, you may evaluate how the addition of Safeguard Scientifics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
The market value of Safeguard Scientifics is measured differently than its book value, which is the value of Safeguard that is recorded on the company's balance sheet. Investors also form their own opinion of Safeguard Scientifics' value that differs from its market value or its book value, called intrinsic value, which is Safeguard Scientifics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Safeguard Scientifics' market value can be influenced by many factors that don't directly affect Safeguard Scientifics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Safeguard Scientifics' value and its price as these two are different measures arrived at by different means. Investors typically determine Safeguard Scientifics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Safeguard Scientifics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.